Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?

Wei, Jun, Melichian, Denisa, Komura, Kazuhiro, Hinchcliff, Monique, Lam, Anna P., Lafyatis, Robert, Gottardi, Cara J., MacDougald, Ormond A. +1 more·2011·Arthritis & Rheumatism

Cited by (215)

Items 101–200 of 215

  1. Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis
    John Henderson, Max Brown, Steven Horsburgh, Laura Duffy, Sarah Wilkinson, Julie C. Worrell, Richard J. Stratton, Steven O’Reilly · 2018 · Lara D. Veeken
  2. Inactivation of evenness interrupted (EVI) reduces experimental fibrosis by combined inhibition of canonical and non-canonical Wnt signalling
    Alfiya Distler, Clara Ziemer, Christian Beyer, Neng‐Yu Lin, Chih‐Wei Chen, Katrin Palumbo‐Zerr, Clara Dees, Alexander Weidemann, Oliver Distler, Georg Andreas Schett et al. · 2013 · Annals of the Rheumatic Diseases
  3. Recent advances in animal models of systemic sclerosis
    Yoshihide Asano · 2016 · The Journal of Dermatology
  4. Wnt antagonist DKK‐1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a‐3p
    John Henderson, Stefan Pryzborski, Richard J. Stratton, Steven O’Reilly · 2020 · Experimental Dermatology
  5. Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines
    Minoru Hasegawa, Kazuhiko Takehara · 2012 · Seminars in Arthritis and Rheumatism
  6. Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model
    Mesias Pedroza, Robert L. Welschhans, Sandeep Krishna Agarwal · 2017 · PLoS ONE
  7. Aberrant expression of Wnt family contributes to the pathogenesis of diabetes‐induced erectile dysfunction
    S. H. Shin, W. J. Kim, Min Ji Choi, J.‐M. Park, Hai‐Rong Jin, Guo Nan Yin, Ji‐Kan Ryu, J.‐K. Suh · 2013 · Andrology
  8. Interfacial Adipose Tissue in Systemic Sclerosis
    Ilja L. Kruglikov · 2017 · Current Rheumatology Reports
  9. A multiscale hybrid mathematical model of epidermal‐dermal interactions during skin wound healing
    Yangyang Wang, Christian Fernando Guerrero‐Juarez, Yuchi Qiu, Huijing Du, Weitao Chen, Seth Figueroa, Maksim V. Plikus, Qing Hua Nie · 2019 · Experimental Dermatology
  10. Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease
    Yun Zhang, Lichong Shen, Katja Dreißigacker, Honglin Zhu, Thuong Trinh‐Minh, Xianyi Meng, Cuong Tran Manh, Clara Dees, Alexandru‐Emil Matei, Chih‐Wei Chen et al. · 2021 · Blood
  11. Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications
    Mirko Manetti, Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, Emanuela Praino, Serena Guiducci, Florenzo Iannone, Lidia Ibba‐Manneschi, Marco Matucci‐Cerinic · 2019 · Journal of Clinical Medicine
  12. Whole-genome bisulfite sequencing in systemic sclerosis provides novel targets to understand disease pathogenesis
    Tianyuan Lu, Kathleen Klein, Inés Colmegna, Maximilien Lora, Celia M.T. Greenwood, Marie Hudson · 2019 · BMC Medical Genomics
  13. The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting
    Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, Marco Matucci‐Cerinic, Mirko Manetti · 2021 · Current Molecular Medicine
  14. Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies
    Joanna Wiśniewska, Agnieszka Sadowska, Anna Wójtowicz, Magda Słyszewska, Anna Zuzanna Szóstek-Mioduchowska · 2021 · Life
  15. Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling
    Lauren M. Reinke, Anna P. Lam, Annette S. Flozak, John Varga, Cara J. Gottardi · 2016 · Biochemical and Biophysical Research Communications
  16. Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
    Milos Antic, Jörg H. W. Distler, Oliver Distler · 2013 · Current Opinion in Pharmacology
  17. A High Throughput Screen Identifies Nefopam as Targeting Cell Proliferation in β-Catenin Driven Neoplastic and Reactive Fibroproliferative Disorders
    Raymond W.M. Poon, Helen Hong, Xin Wei, James Pan, Benjamin Aaron Alman · 2012 · PLoS ONE
  18. Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs
    Wenxia Wang, Swarna Bale, Jun Wei, Bharath Yalavarthi, Dibyendu Bhattacharyya, Jing Jing Yan, Hiam Abdala‐Valencia, Dan Xu, Hanshi Sun, Roberta Gonçalves Marangoni et al. · 2022 · Nature Communications
  19. From pathogenesis to therapy – Perspective on treatment strategies in fibrotic diseases
    Andreas Ramming, Clara Dees, Jörg H. W. Distler · 2015 · Pharmacological Research
  20. The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthropathies and scleroderma?
    Kalliopi Klavdianou, Stamatis‐Nick C. Liossis, Lazaros I. Sakkas, Dimitrios Daoussis · 2016 · Seminars in Arthritis and Rheumatism
  21. Promising small molecule anti-fibrotic agents: Newly developed or repositioned drugs targeting myofibroblast transdifferentiation
    Shin Ishikane, Masaki Arioka, Fumi Takahashi‐Yanaga · 2023 · Biochemical Pharmacology
  22. Lysyl hydroxylase 3 increases collagen deposition and promotes pulmonary fibrosis by activating TGFβ1/Smad3 and Wnt/β-catenin pathways
    Songjun Shao, Haiyan Fang, Lindi Duan, Xianwei Ye, Shanshan Rao, Jin‐Hee Han, Yumei Li, Guohang Yuan, Weijia Liu, Xiangyan Zhang · 2019 · Archives of Medical Science
  23. Dermal white adipose tissue: A new modulator in wound healing and regeneration
    Zhongyu Wu, Zhanqi Wang, Tao Chen, Dongyang Wang, Feng Zhou, Guorui Zhang, Shan Wei, Yingying Wu · 2024 · Regenerative Therapy
  24. Inhibition by Chondroitin Sulfate E Can Specify Functional Wnt/β-Catenin Signaling Thresholds in NIH3T3 Fibroblasts
    Catherine Willis, Michael Klüppel · 2012 · Journal of Biological Chemistry
  25. Beta‐catenin causes fibrotic changes in the extracellular matrix via upregulation of collagen I transcription
    Mi Ryung Roh, Raj Kumar, Anpuchchelvi Rajadurai, Ching-Ni Jenny Njauw, U.H. Ryoo, Kee Yang Chung, Hensin Tsao · 2016 · British Journal of Dermatology
  26. Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis
    Jörg H. W. Distler, David Launay, Carol A. Feghali‐Bostwick, Alexandru-Emil Matei, Maria E. Trojanowska, Johann Eli Gudjonsson · 2026 · Nature Reviews Rheumatology
  27. Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma
    Kazuyuki Tsujino, Dean Sheppard · 2015 · Current Rheumatology Reports
  28. Updates on animal models of systemic sclerosis
    Alina Soare, Andreas Ramming, Jérôme Avouac, Jörg H. W. Distler · 2016 · Journal of Scleroderma and Related Disorders
  29. Pregnancy in Rheumatic Disease Patients
    Lisa R. Sammaritano · 2013 · JCR Journal of Clinical Rheumatology
  30. Genome-wide DNA methylation pattern in systemic sclerosis microvascular endothelial cells: Identification of epigenetically affected key genes and pathways
    Shadia E. Nada, Bashar Kahaleh, Nezam Altorok · 2021 · Journal of Scleroderma and Related Disorders
  31. Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis
    Theodoros Dimitroulas, Dimitrios Daoussis, Alexandros Garyfallos, Petros Paul Sfikakis, George D. Kitas · 2015 · Current Medicinal Chemistry
  32. Role of WNT10A-Expressing Kidney Fibroblasts in Acute Interstitial Nephritis
    Akihiro Kuma, Sohsuke Yamada, Ke‐Yong Wang, Noriaki Kitamura, Takahiro Yamaguchi, Yoshiko Iwai, Hiroto Izumi, Masahito Tamura, Yutaka Otsuji, Kimitoshi Kohno · 2014 · PLoS ONE
  33. The non-neuronal cyclin-dependent kinase 5 is a fibrotic mediator potentially implicated in systemic sclerosis and a novel therapeutic target
    Jun Wei, Roberta Gonçalves Marangoni, Feng Fang, Wenxia Wang, Jingang Huang, Joerg H W Distler, John Varga · 2017 · Oncotarget
  34. Targeting the Wnt signaling pathway: the challenge of reducing scarring without affecting repair
    Edward J. Jarman, Luke Boulter · 2020 · Expert Opinion on Investigational Drugs
  35. Transplantation of in vitro prefabricated adipose organoids attenuates skin fibrosis by restoring subcutaneous fat and inducing dermal adipogenesis
    Yuping Quan, Yuteng Zhang, Jian Li, Feng Lu, Junrong Cai · 2023 · The FASEB Journal
  36. Emerging targeted therapies in scleroderma lung and skin fibrosis
    Britta Maurer, Oliver Distler · 2011 · Best Practice & Research Clinical Rheumatology
  37. SSc—fibrosis takes flight with Wingless inhibition
    Robert Lafyatis · 2012 · Nature Reviews Rheumatology
  38. X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)
    Christina Bergmann, Ludwig Hallenberger, Sara Chenguiti Fakhouri, Benita Merlevede, Amelie Brandt, Clara Dees, Honglin Zhu, Ariella Zehender, Xiang Zhou, Annemarie Schwab et al. · 2021 · Annals of the Rheumatic Diseases
  39. Insight into the role of dermal white adipose tissue loss in dermal fibrosis
    Si‐Yu Liu, Jun‐Jie Wu, Zhong‐Hua Chen, Ming‐Li Zou, Ying‐Ying Teng, Kai‐Wen Zhang, Yue‐Yue Li, Dang‐Yang Guo, Feng‐Lai Yuan, Xia Li · 2021 · Journal of Cellular Physiology
  40. The intracellular chloride channel 4 (CLIC4) activates systemic sclerosis fibroblasts
    Christopher W. Wasson, Rebecca L. Ross, Ruth Morton, Jamel Mankouri, Francesco Del Galdo · 2020 · Lara D. Veeken
  41. Targeting the myofibroblast to improve wound healing
    Boris Hinz · 2016 · Elsevier eBooks
  42. Tissue fibrosis associated depletion of lipid‐filled cells
    Anna R. Jussila, Brian Zhang, Sakin Kirti, Radhika P. Atit · 2024 · Experimental Dermatology
  43. Etiology and pathogenesis of systemic sclerosis
    John Varga, Robert Lafyatis · 2015 · Elsevier eBooks
  44. Intimate intertwining of the pathogenesis of hypoxia and systemic sclerosis: A transcriptome integration analysis
    Xinglan He, Yaqian Shi, Zhuotong Zeng, Bingsi Tang, Xuan Xiao, Jiangfan Yu, Puyu Zou, Jiani Liu, Yangfan Xiao, Yangyang Luo et al. · 2022 · Frontiers in Immunology
  45. Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation
    Pengpeng Yan, Huanna Tang, Xiaoying Chen, Shuiyu Ji, Jin jia Wei, Jiaming Zhang, Jia Yun Shen, Hao Deng, Xiang Zhao, Quanquan Shen et al. · 2018 · Bioscience Reports
  46. Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt/β-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model
    Qian Wang, Wenhua Zang, Li Han, Lei Yang, Songshan Ye, Jingfeng Ouyang, Chaoyun Zhang, Yuefeng Bi, Cuiyue Zhang, Hua Bian · 2018 · Chinese Medicine
  47. Therapeutic molecular targets of SSc-ILD
    Yun Zhang, Jörg H. W. Distler · 2020 · Journal of Scleroderma and Related Disorders
  48. Narrowband UVB treatment induces expression of WNT7B, WNT10B and TCF7L2 in psoriasis skin
    Malin Assarsson, Jan Söderman, Albert Duvetorp, Ulrich Mrowietz, Marita Skarstedt, Oliver Seifert · 2019 · Archives of Dermatological Research
  49. Suppressor of Fused Inhibits Skin Wound Healing
    Beibei Yang, Yu-Xin Zheng, Bing‐Xi Yan, Hua-Li Cao, Lilla Landeck, Jiaqi Chen, Wei Li, Min Min, Ping Wang, Sui‐Qing Cai et al. · 2019 · Advances in Wound Care
  50. Genetic Interactions Affect Lung Function in Patients with Systemic Sclerosis
    Anna L. Tyler, J. Matthew Mahoney, Gregory W. Carter · 2019 · G3 Genes Genomes Genetics
  51. Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?
    Yuxuan Xiao, Roberto I. Vázquez-Padrón, Laisel Martinez, Harold A. Singer, Daniel Woltmann, Loay H. Salman · 2022 · The Journal of Vascular Access
  52. What Lies Beneath: Wnt/β-Catenin Signaling and Cell Fate in the Lower Dermis
    Colin A.B. Jahoda, Adam Gilmore · 2016 · Journal of Investigative Dermatology
  53. Etiology and Pathogenesis of Scleroderma
    John Varga · 2013 · Elsevier eBooks
  54. Etiology and Pathogenesis of Scleroderma
    John Varga · 2016 · Elsevier eBooks
  55. Basic fibroblast growth factor activates β-catenin/RhoA signaling in pulmonary fibroblasts with chronic obstructive pulmonary disease in rats
    Zhengxing Ge, Bo Li, Xun Zhou, Yi Yang, Jun Zhang · 2016 · Molecular and Cellular Biochemistry
  56. Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling
    Aleix Rius Rigau, Clara Dees · 2024 · Fibrosis
  57. Pathophysiology of Fibrosis in Systemic Sclerosis
    Maria Trojanowska, John Varga · 2016 · Springer eBooks
  58. Relationship of Wnt pathway activity and organ involvement in scleroderma types
    Ayşe Koçak, Duygu Harmancı, Gül Güner, Merih Bırlık · 2020 · International Journal of Rheumatic Diseases
  59. The Exciting Future for Scleroderma
    Jörg H. W. Distler, Gabriela Riemekasten, Christopher Paul Denton · 2023 · Rheumatic Disease Clinics of North America
  60. A broad look into the future of systemic sclerosis
    Gabriela Riemekasten, Jörg H. W. Distler · 2022 · Therapeutic Advances in Musculoskeletal Disease
  61. Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies
    Amanda Saracino, Daniel Kelberman, Georg Otto, Andrey N. Gagunashvili, David Abraham, Christopher Paul Denton · 2023 · Archives of Dermatological Research
  62. Biomarkers in Skin Autoimmunity—An Update on Localised Scleroderma
    Adrian H. Bustos, Begoña Bolós, Kira Astakhova · 2024 · Skin Health and Disease
  63. Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis
    Himanshu N. Bhatt, Rimpy Diwan, Igor L. Estevao, Rui Dong, Jennifer Smith, Chuan Xiao, Sandeep Krishna Agarwal, Md Nurunnabi · 2024 · Journal of Controlled Release
  64. Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies
    Bénédict Fallet, Ulrich Andreas Walker · 2020 · Expert Review of Clinical Pharmacology
  65. Systemic Sclerosis, Scleroderma
    Nabeel H. Borazan, Daniel E. Fürst · 2013 · Elsevier eBooks
  66. Overview of Animal Models
    Yoshihide Asano, Jörg H. W. Distler · 2016 · Springer eBooks
  67. Antifibrotic therapeutic strategies in systemic sclerosis: Critical role of the Wnt/β-catenin and TGF-β signal transduction pathways as potential targets
    Leyla Bagheri, Mohammad Javanbakht, Sheida Malekian, Bahareh Heshmat Ghahderijani, Sadra Taghipour, Fatemeh Davari Tanha, Mohammad Hossein Ranjkesh, Luca Cegolon, Shi Guang Zhao · 2025 · European Journal of Pharmacology
  68. Scleroderma: recent lessons from murine models and implications for future therapeutics
    Takashi Matsushita, Manabu Fujimoto · 2013 · Expert Review of Dermatology
  69. Fibrogenesis, novel lessons from animal models
    Ellen De Langhe, Rik Jozef Urbain Lories · 2015 · Seminars in Immunopathology
  70. Paricalcitol Inhibits Wnt/β-Catenin Signaling Pathway and Ameliorates Dermal Fibrosis in Bleomycin Induced Scleroderma Model
    Nevzat Gözel, Fikret DURAN, Ahmet YILDIRIM, Servet YOLBAŞ, Ebru ÖNALAN, İbrahim Hanifi ÖZERCAN, Süleyman Serdar Koca · 2018 · Archives of Rheumatology
  71. Developmental regulation of dermal adipose tissue by BCL11b
    Sarah Traynor, Shashwati Bhattacharya, Kirill Batmanov, Lan Cheng, Angela H. Weller, Natalie Moore, Carmen G. Flesher, David Merrick · 2024 · Genes & Development
  72. Fibrosis mechanisms and updates in potential therapeutic targets in systemic sclerosis
    Xue Han, Xiuyuan Wang, Junxia Huang, Ji Young Yang · 2025 · Seminars in Arthritis and Rheumatism
  73. A mechanomimetic model of skin fibrosis
    Alberto Pappalardo, Deniz Örnek, Laura Garriga-Cerda, Charlotte Yi-Lan Lee, Kristin M. Myers, Jeffrey W. Kysar, Hasan Erbil Abaci · 2025 · Lab on a Chip
  74. Wnt-associated DKK3 in keratinocytes mediates radiation-induced hyperplasia, dermatitis and skin fibrosis
    Li Li, Ramon Lopez Perez, Khuram Shehzad, Richard Jennemann, Claudia Schmidt, Thomas Walle, Alexandra Tietz-Dahlfuß, Elisabeth Grimm, Joscha A. Kraske, Peter Häring et al. · 2026 · Signal Transduction and Targeted Therapy
  75. Fibrosis mechanisms in systemic sclerosis and new potential therapies
    Raffaele Barile, Cinzia Rotondo, Valeria Rella, Antonello Trotta, Francesco Paolo Cantatore, Addolorata Corrado · 2024 · Postgraduate Medical Journal
  76. Mechanism of Fibrosis
    John Varga · 2011 · Springer eBooks
  77. Molecular pathogenesis of fibrosis in systemic sclerosis
    Masatoshi Jinnin · 2022 · Trends in Immunotherapy
  78. Disturbed Spatial WNT Activation—A Potential Driver of the Reticularized Skin Phenotype in Systemic Sclerosis
    Sara Chenguiti Fakhouri, Honglin Zhu, Yinan Li, Moritz Ronicke, Aleix Rius Rigau, Clara Dees, Laura Konstantinidis, Ralf Schmid, Alexandru‐Emil Matei, Markus Eckstein et al. · 2024 · Arthritis & Rheumatology
  79. Deletion of TXNDC5 downregulates TGFβ1-αSMA-mediated testicular fibrosis in mice
    Ya-Yi Yang, Yi-Min Chiang, Kai‐Chien Yang, Pei‐Shiue Tsai · 2025 · Reproduction
  80. WISP-2 - A Novel Adipokine Related to Obesity and Insulin resistance
    John R. Grünberg · 2015 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  81. TGF-β-driven downregulation of the Wnt/β-Catenin transcription factor TCF7L2/TCF4 in PDGFRα + fibroblasts
    Osvaldo Contreras, Hesham Soliman, Marine Théret, Fabio M V Rossi, Enrique Brandan · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Epigenetics of autoimmune diseases
    Elham Farhadi, Mahdi Mahmoudi · 2019 · Elsevier eBooks
  83. Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis
    Suneeti R. Madhavan, Piper Moore, Rohan Varshney, Miles Montegut, Qiannan Ma, Kayla Klatt, Reshmi Parameswaran, Elif G. Ertugral, Chandrasekhar R. Kothapalli, Michael C. Rudolph et al. · 2026 · The Journal of Pathology
  84. Developments into understanding the pathogenesis of systemic sclerosis
    Nicolas Hunzelmann · 2013 · Expert Review of Dermatology
  85. Cutaneous Fibrosis and Normal Wound Healing
    Emily Hamburg‐Shields, Peggy S. Myung, Shawn E. Cowper · 2017 · Springer eBooks
  86. [Research progress of hair follicle and related stem cells in scar-free wound healing].
    Zhentao Zhou, Qinyuan Zhao, Jun Zhao, Jufang Zhang · 2021 · PubMed Central
  87. Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis
    Maria Trojanowska, John Varga, David Lagares · 2024 · Springer eBooks
  88. Overview of Animal Models
    Christopher Paul Denton, Robert Lafyatis · 2011 · Springer eBooks
  89. The cellular microenvironment: a new target in the search for cellular and molecular treatment for Dupuytren’s disease
    David B. O’Gorman, Bing Siang Gan · 2014 · Expert Opinion on Orphan Drugs
  90. Valvular interstitial cell transformation : implications for aortic valve calcification
    Seti Boroomand · 2014 · cIRcle (University of British Columbia)
  91. The WNT signalling pathway in systemic sclerosis
    Jacqueline Frost · 2016
  92. Morphogen and epigenetic regulation of wound healing
    Laura Corbett · 2015
  93. Aberrant Recapitulation of Developmental Program: Novel Target in Scleroderma
    Robert Lafyatis · 2015
  94. Pathogenesis of morphoea: knowledge gaps in subtypes and comparisons to systemic sclerosis
    Benjamin F. Chong · 2017 · British Journal of Dermatology
  95. Epigenetics of Systemic Sclerosis
    Nezam Altorok, Vivek Nagaraja, Bashar Kahaleh · 2017 · Springer eBooks
  96. Skin in vitro models to study dermal white adipose tissue role in skin healing
    Manuela E. L. Lago, Mariana T. Cerqueira, Rogério Pedro Pirraco, Rui Luís Reis, Alexandra P. Marques · 2017 · Elsevier eBooks
  97. Characterisation of Embryonic Dermal Precursor Cells
    Sarah Blincko · 2018 · Durham e-Theses (Durham University)
  98. The Effect of Function-blocking RHAMM Peptides in a Mouse Model of Bleomycin-induced Systemic Sclerosis
    Kitty Yuechuan Wu · 2018 · Scholarship@Western (Western University)
  99. Epigenetics and Systemic Sclerosis
    Nezam Altorok, Amr H. Sawalha · 2015 · Elsevier eBooks
  100. WNT5A induziert über eine JNK-abhängige Aktivierung von latentem TGF-β Fibrose
    Chih‐Wei Chen · 2017 · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)